CANDEL THERAPEUTICS, INC. (CADL)
Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Valvoline Announces Commencement of Senior Notes Offering
Financial Statements and Related Announcement: Half Yearly Results
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
Studio City International Holdings Limited Announces Unaudited Second Quarter 2026 Earnings
Melco Resorts Announces Unaudited Second Quarter 2026 Earnings
NextPlat Reports 21% Sequential Quarterly Revenue Growth, 87% Reduction in Quarterly Net Loss to $144,000 and Record Gross Margin of Approximately 40%
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement
Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
HTCO Highlights Strengthening Dry Bulk Market as BDI Rises Approximately 9.2% in July and Shipping Equities Gain Investor Attention